Literature DB >> 9486719

Frontoparietal scleroderma (en coup de sabre) following Blaschko's lines.

Y Soma1, M Fujimoto.   

Abstract

We describe three patients with frontoparietal scleroderma showing multiple lesions. The lesions were in two different lines that seemed to belong to Blaschko's lines. It remains controversial whether linear scleroderma follows Blaschko's lines, but our observations presented here suggest that frontoparietal scleroderma occurs along the lines of Blaschko.

Entities:  

Mesh:

Year:  1998        PMID: 9486719     DOI: 10.1016/s0190-9622(98)70586-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Linear scleroderma en coup de sabre affecting the upper eyelid and lashes.

Authors:  Katrina A Mears; J Javier Servat; Evan H Black
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-17       Impact factor: 3.117

Review 2.  X chromosome inactivation and female predisposition to autoimmunity.

Authors:  Tayfun Ozcelik
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

3.  Concurrence of Circumscribed Morphea and Segmental Vitiligo: A Case Report.

Authors:  Ji Su Lee; Hyun-Sun Park; Soyun Cho; Hyun-Sun Yoon
Journal:  Ann Dermatol       Date:  2018-10-26       Impact factor: 1.444

4.  Segmental vitiligo with segmental morphea: An autoimmune link?

Authors:  Pravesh Yadav; Taru Garg; Ram Chander; Anita Nangia
Journal:  Indian Dermatol Online J       Date:  2014-11

5.  Neurologic involvement in scleroderma en coup de sabre.

Authors:  Tiago Nardi Amaral; João Francisco Marques Neto; Aline Tamires Lapa; Fernando Augusto Peres; Caio Rodrigues Guirau; Simone Appenzeller
Journal:  Autoimmune Dis       Date:  2012-01-27

Review 6.  Localized scleroderma: clinical spectrum and therapeutic update.

Authors:  Mariana Figueiroa Careta; Ricardo Romiti
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.